GLP-1 Price Check

Patient assistance programs

Both manufacturers run assistance programs that can reduce or eliminate the cost of medication for patients below an income threshold. They are the least visible pathway and often the cheapest one for the people who qualify.

Pricing data as of .

Who can use this, and what to watch for

Every point below comes from the same data file that drives the price table, so it cannot drift from the figures on this page.

You need

Worth knowing

Some rules above are applied from program terms we have not yet been able to read directly. Where that is so, we apply the rule that narrows your options rather than widens them, because telling someone a discount is available when it is not is the more damaging error. How we handle unverified rules.

How they differ from a savings card

A savings card reduces a copay for someone who already has commercial insurance. A patient assistance program supplies medication to someone who largely cannot pay for it, and eligibility turns on household income relative to the federal poverty level rather than on what insurance you hold.

They are application-based, usually require proof of income and prescriber involvement, and approval is not immediate. If you need medication this week, this is not the pathway that solves that week.

What we have not verified

We could not retrieve the current income thresholds, the household-size tables, or the list of covered products from either manufacturer, so we publish no threshold figures. We show the pathway with its income caveat and link to the official program pages, which is more useful than a threshold we would be guessing at.

Every figure we hold for this pathway

Medication Pathway Dose or tier Monthly Confidence Source type Verified Source
Zepbound Patient assistance program any Not verified Not verified Primary, manufacturer 2026-07-30 Open
Wegovy Patient assistance program any Not verified Not verified Primary, manufacturer 2026-07-30 Open
Ozempic Patient assistance program any Not verified Not verified Primary, manufacturer 2026-07-30 Open
Mounjaro Patient assistance program any Not verified Not verified Primary, manufacturer 2026-07-30 Open
Wegovy tablets Patient assistance program any Not verified Not verified Primary, manufacturer 2026-07-30 Open
Foundayo Patient assistance program any Not verified Not verified Primary, manufacturer 2026-07-30 Open

Compare it against everything else

A single pathway in isolation cannot tell you whether it is your cheapest option. Use the tool to rank this pathway against every other one for your medication, your insurance situation and your dose.